Insights
Deep tech start-ups get $50m boost with new national incubator programme
SINGAPORE – Deep tech start-ups can now tap a $50 million fund over the next five years under a new incubator programme managed by Singapore’s two leading universities.
To be launched in January 2025, the National Graduate Research Innovation Programme (Grip) will support aspiring locally-based researchers and entrepreneurs who have developed innovations in areas such as artificial intelligence, space, smart city and semiconductor ..READ MORE
Rewriting the Manufacturing of Biologics Using AI
Cell therapy has changed the way we treat auto-immune diseases and cancer, but manufacturing these life-saving treatments is still expensive and complex. ChemT Biotechnology, a company founded in October 2024 by leading scientists and entrepreneurs, hopes to change that. By using AI-designed small molecules, they aim to make immune cell therapy manufacturing faster, more cost-effective and scalable.
At present, CAR-T, TCR-T and TIL are types of immunotherapy that use a patient's own T-cells to fight cancer. The key difference is that CAR-T cells are genetically engineered in a lab to target a specific antigen in cancer cells, while TILs (tumour-infiltrating lymphocytes) are T-cells that are ..READ MORE
NTU launches AI-powered screening tool to detect pre-dementia in 15 minutes
SINGAPORE – Mild cognitive impairment, or pre-dementia, affects as many as 12.5 per cent of Singapore’s population, but diagnosing the condition can be costly and time-consuming.
A new screening tool powered by artificial intelligence promises to make the process more efficient and affordable, identifying early signs of cognitive impairment within just 15 minutes.
It was officially launched on Feb 4, following three years of research and development. ..READ MORE
